Finansiella nyckeltal BIO-key International, Inc.
Aktier
BKYI
US09060C6066
Elektronisk utrustning & delar
|
Fördröjd
Andra börsplatser
|
5-dagars förändring | Förändring 1 jan. | ||
| 4,100 USD | 0,00 % |
|
−3,98 % | −23,95 % |
| Skatteperiod: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Lönsamhet | ||||||||||
Return on Assets | −26 | −15,33 | −34,5 | −69,56 | −38,18 | |||||
Return on Total Capital | −29,85 | −16,72 | −41,13 | −110,65 | −71,85 | |||||
Return On Equity % | −107,19 | −28,18 | −113,88 | −267,77 | −177,88 | |||||
Return on Common Equity | −108,44 | −28,18 | −113,88 | −267,77 | −177,88 | |||||
Marginalanalys | ||||||||||
Gross Profit Margin % | 71,98 | 67,29 | 65,25 | 18,46 | 81,39 | |||||
SG&A Margin | 206,17 | 117,87 | 133,4 | 101,39 | 103,7 | |||||
EBITDA Margin % | −177,64 | −93,8 | −109,6 | −108,27 | −52,14 | |||||
EBITA Margin % | −180,66 | −94,86 | −110,23 | −109,24 | −53,48 | |||||
EBIT Margin % | −183,42 | −96,62 | −114,47 | −113,82 | −57,88 | |||||
Income From Continuing Operations Margin % | −341,02 | −99,05 | −169,65 | −109,89 | −62,06 | |||||
Net Income Margin % | −341,02 | −99,05 | −169,65 | −109,89 | −62,06 | |||||
Net Avail. For Common Margin % | −344,99 | −99,05 | −169,65 | −109,89 | −62,06 | |||||
Normalized Net Income Margin | −209,65 | −61,9 | −81,85 | −73,12 | −39 | |||||
Levered Free Cash Flow Margin | −50,25 | −128,95 | −42,35 | 0,89 | −17,2 | |||||
Unlevered Free Cash Flow Margin | −103,78 | −129,08 | −48,39 | 2,65 | −16,29 | |||||
Tillgångsomslutning | ||||||||||
Asset Turnover | 0,23 | 0,25 | 0,48 | 0,98 | 1,06 | |||||
Fixed Assets Turnover | 4,61 | 11,46 | 22,36 | 27,6 | 29,45 | |||||
Receivables Turnover (Average Receivables) | 6,71 | 6,28 | 5,42 | 5,4 | 6,62 | |||||
Inventory Turnover (Average Inventory) | 2,09 | 0,63 | 0,52 | 2,59 | 3,13 | |||||
Kortfristig likviditet | ||||||||||
Current Ratio | 10,1 | 7,01 | 1,65 | 0,82 | 0,41 | |||||
Quick Ratio | 9,65 | 4,39 | 0,77 | 0,56 | 0,27 | |||||
Operating Cash Flow to Current Liabilities | −2,64 | −4,49 | −1,14 | −1,18 | −0,64 | |||||
Days Sales Outstanding (Average Receivables) | 54,54 | 58,11 | 67,39 | 67,61 | 55,28 | |||||
Days Outstanding Inventory (Average Inventory) | 175 | 575,08 | 701,33 | 140,84 | 116,96 | |||||
Average Days Payable Outstanding | 285,99 | 19,52 | 145 | 189,48 | 319,62 | |||||
Cash Conversion Cycle (Average Days) | −56,45 | 613,68 | 623,72 | 18,97 | −147,38 | |||||
Långsiktig solvens | ||||||||||
Total Debt/Equity | 3,59 | 1,69 | 61,12 | 34,35 | 47,11 | |||||
Total Debt / Total Capital | 3,47 | 1,66 | 37,94 | 25,57 | 32,02 | |||||
LT Debt/Equity | 1,3 | 0,56 | 6,88 | 17,75 | 2,49 | |||||
Long-Term Debt / Total Capital | 1,25 | 0,55 | 4,27 | 13,21 | 1,69 | |||||
Total Liabilities / Total Assets | 9,7 | 12,12 | 53,27 | 76,45 | 56,22 | |||||
EBIT / Interest Expense | −1,2 | −274,55 | −6,94 | −40,44 | −13,38 | |||||
EBITDA / Interest Expense | −1,11 | −252,29 | −6,43 | −37,71 | −11,9 | |||||
(EBITDA - Capex) / Interest Expense | −1,11 | −254,63 | −6,5 | −37,71 | −11,94 | |||||
Total Debt / EBITDA | −0,15 | −0,06 | −0,44 | −0,04 | −0,5 | |||||
Net Debt / EBITDA | 3,49 | 1,65 | −0,08 | 0,02 | −0,38 | |||||
Total Debt / (EBITDA - Capex) | −0,15 | −0,06 | −0,43 | −0,04 | −0,5 | |||||
Net Debt / (EBITDA - Capex) | 3,47 | 1,63 | −0,08 | 0,02 | −0,37 | |||||
Tillväxt jämfört med föregående år | ||||||||||
Total Revenues, 1 Yr. Growth % | 25,1 | 80,29 | 37,26 | 10,46 | −10,64 | |||||
Gross Profit, 1 Yr. Growth % | −1,15 tn | 68,54 | 33,1 | −68,75 | 294,06 | |||||
EBITDA, 1 Yr. Growth % | −21,9 | −4,8 | 64,72 | 9,12 | −56,97 | |||||
EBITA, 1 Yr. Growth % | −21,56 | −5,33 | 63,75 | 9,48 | −56,25 | |||||
EBIT, 1 Yr. Growth % | −20,71 | −5,02 | 62,62 | 9,83 | −54,56 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | −33,69 | −47,64 | 135,1 | −28,45 | −49,53 | |||||
Net Income, 1 Yr. Growth % | −33,69 | −47,64 | 135,1 | −28,45 | −49,53 | |||||
Normalized Net Income, 1 Yr. Growth % | 24,7 | −46,76 | 83,67 | −1,33 | −52,34 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | - | −68,77 | 126,14 | −44,21 | −86,27 | |||||
Accounts Receivable, 1 Yr. Growth % | 156,82 | 67,65 | 54,13 | −17,26 | −39,09 | |||||
Inventory, 1 Yr. Growth % | −22,88 | 1,39 tn | −10,25 | −89,95 | −15,13 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | −14,03 | −43,2 | −5,72 | −15,65 | −16,93 | |||||
Total Assets, 1 Yr. Growth % | 802,01 | −21,1 | −36,16 | −60,18 | 90,73 | |||||
Tangible Book Value, 1 Yr. Growth % | −796,26 | −25,68 | −72,79 | −109,73 | −876,48 | |||||
Common Equity, 1 Yr. Growth % | −989,87 | −23,21 | −66,05 | −79,94 | 254,66 | |||||
Cash From Operations, 1 Yr. Growth % | 167,52 | 81,38 | −30,62 | −39,1 | −23,18 | |||||
Capital Expenditures, 1 Yr. Growth % | 23,7 | 18,15 | 95,22 | −98,78 | 1,2 tn | |||||
Levered Free Cash Flow, 1 Yr. Growth % | −172,96 | 362,63 | −54,92 | −102,32 | 1,2 tn | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | −281,08 | 124,25 | −48,54 | −106,04 | −2,61 tn | |||||
Sammansatt Årlig Tillväxthastighet Över Två År | ||||||||||
Total Revenues, 2 Yr. CAGR % | −16,25 | 50,18 | 57,31 | 23,14 | −0,65 | |||||
Gross Profit, 2 Yr. CAGR % | 313,11 | 321,5 | 49,78 | −35,51 | 10,96 | |||||
EBITDA, 2 Yr. CAGR % | −13,72 | −13,77 | 23,57 | 34,07 | −31,48 | |||||
EBITA, 2 Yr. CAGR % | −13,52 | −13,83 | 22,88 | 33,89 | −30,8 | |||||
EBIT, 2 Yr. CAGR % | −12,97 | −13,22 | 24,28 | 33,64 | −29,35 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 18,68 | −41,07 | 10,96 | 29,7 | −39,91 | |||||
Net Income, 2 Yr. CAGR % | 18,68 | −41,07 | 10,96 | 29,7 | −39,91 | |||||
Normalized Net Income, 2 Yr. CAGR % | 17,7 | −18,52 | −1,7 | 34,62 | −31,42 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | - | - | −15,96 | 14 | −72,33 | |||||
Accounts Receivable, 2 Yr. CAGR % | −38,91 | 107,49 | 60,74 | 12,92 | −29,01 | |||||
Inventory, 2 Yr. CAGR % | −42,44 | 239,32 | 266,05 | −69,96 | −70,79 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 95,7 | −30,12 | −26,82 | −10,82 | −16,29 | |||||
Total Assets, 2 Yr. CAGR % | 38,78 | 166,78 | −29,03 | −49,58 | −12,85 | |||||
Tangible Book Value, 2 Yr. CAGR % | 124,26 | 127,48 | −55,03 | −83,73 | −13,07 | |||||
Common Equity, 2 Yr. CAGR % | 39,39 | 161,41 | −48,94 | −73,9 | −15,65 | |||||
Cash From Operations, 2 Yr. CAGR % | 75,16 | 120,28 | 12,18 | −35 | −31,6 | |||||
Capital Expenditures, 2 Yr. CAGR % | −17,34 | 20,89 | 51,87 | −84,57 | −60,12 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 380,17 | 83,72 | 44,42 | −89,78 | −36,69 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 590,03 | 101,51 | 7,42 | −82,36 | −42,36 | |||||
Treårig Sammansatt Årlig Tillväxthastighet | ||||||||||
Total Revenues, 3 Yr. CAGR % | −23,37 | 8,14 | 45,75 | 39,82 | 10,65 | |||||
Gross Profit, 3 Yr. CAGR % | −12,62 | 206,4 | 187,03 | −11,17 | 17,9 | |||||
EBITDA, 3 Yr. CAGR % | 6,18 | −10,84 | 6,05 | 18,55 | −8,21 | |||||
EBITA, 3 Yr. CAGR % | 6,34 | −10,88 | 5,8 | 18,24 | −7,78 | |||||
EBIT, 3 Yr. CAGR % | 6,77 | −10,39 | 6,99 | 19,26 | −6,72 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 31,28 | −9,65 | −6,54 | −4,14 | −5,31 | |||||
Net Income, 3 Yr. CAGR % | 31,28 | −9,65 | −6,54 | −4,14 | −5,31 | |||||
Normalized Net Income, 3 Yr. CAGR % | 30,56 | −9,65 | 6,41 | −1,58 | −4,77 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | - | - | - | −25,96 | −43,71 | |||||
Accounts Receivable, 3 Yr. CAGR % | −41,15 | −14,48 | 87,92 | 28,82 | −8,08 | |||||
Inventory, 3 Yr. CAGR % | −29,56 | 70,38 | 117,81 | 10,44 | −57,54 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 46,46 | 29,57 | −22,78 | −23,27 | −12,91 | |||||
Total Assets, 3 Yr. CAGR % | 11,89 | 14,97 | 65,63 | −41,46 | −21,44 | |||||
Tangible Book Value, 3 Yr. CAGR % | 45,87 | 55,19 | 12,08 | −73 | −40,98 | |||||
Common Equity, 3 Yr. CAGR % | 13,92 | 14,27 | 32,38 | −62,6 | −37,72 | |||||
Cash From Operations, 3 Yr. CAGR % | 26,16 | 77,21 | 49,87 | −8,49 | −31,28 | |||||
Capital Expenditures, 3 Yr. CAGR % | −40,17 | −6,89 | 41,83 | −69,59 | −32,29 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | −19,54 | 374,25 | 15,02 | −63,57 | −43,46 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 2,46 | 374,41 | 27,84 | −58,84 | −44,5 | |||||
Sammansatt Årlig Tillväxthastighet Över Fem År | ||||||||||
Total Revenues, 5 Yr. CAGR % | −11,62 | 11,44 | 2,18 | 13,9 | 25,03 | |||||
Gross Profit, 5 Yr. CAGR % | −12,5 | 8,91 | 8,4 | 64,27 | 96,26 | |||||
EBITDA, 5 Yr. CAGR % | 25,18 | 2,99 | 12,82 | 4,4 | −10,95 | |||||
EBITA, 5 Yr. CAGR % | 24,95 | 2,99 | 12,67 | 4,33 | −10,72 | |||||
EBIT, 5 Yr. CAGR % | 25,13 | 3,3 | 13,45 | 5,14 | −9,38 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 39,11 | 3,87 | 22,74 | 4,41 | −21,67 | |||||
Net Income, 5 Yr. CAGR % | 39,11 | 3,87 | 22,74 | 4,41 | −21,67 | |||||
Normalized Net Income, 5 Yr. CAGR % | 38,65 | 3,87 | 16,55 | 5,72 | −10,74 | |||||
Accounts Receivable, 5 Yr. CAGR % | −29,23 | −8,8 | −12,04 | −4,42 | 27,31 | |||||
Inventory, 5 Yr. CAGR % | 14,43 | 60,39 | 36,18 | −14,9 | −2,49 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 54,87 | 36,66 | 10,96 | 11,58 | −20,25 | |||||
Total Assets, 5 Yr. CAGR % | 1,98 | 0,55 | −6,74 | −17,32 | 28,11 | |||||
Tangible Book Value, 5 Yr. CAGR % | 10,09 | 22,47 | −8,9 | −37,03 | 1,25 | |||||
Common Equity, 5 Yr. CAGR % | 2,3 | 0,21 | −17,36 | −36,7 | 10,54 | |||||
Cash From Operations, 5 Yr. CAGR % | −20,47 | 15,09 | 20,37 | 18,65 | 9,51 | |||||
Capital Expenditures, 5 Yr. CAGR % | 60,27 | −4,53 | −13,15 | −54,64 | −14,62 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | −28,22 | 24,01 | 1,67 | 2,19 | −9,41 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | −16,95 | 24,03 | 4,42 | 27,13 | −7,04 |
- Börsen
- Aktier
- BKYI Aktie
- Finanser BIO-key International, Inc.
- Finansiella nyckeltal
Välj din utgåva
All finansiell information anpassad till den nationella nivån
















